Dr. Babak Edraki, MD
Claim this profileJohn Muir Medical Center-Concord Campus
Studies Cancer
Studies Ovarian Cancer
8 reported clinical trials
25 drugs studied
Area of expertise
1Cancer
Stage IV
Stage II
Stage III
2Ovarian Cancer
Stage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Babak Edraki, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase II/III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin HylectaTM) or pertuzumab, trastuzumab and hyaluronidase-zzxf (PhesgoTM) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma.
Recruiting1 award Phase 2 & 3
More about Babak Edraki, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Babak Edraki, MD has experience with
- External Beam Radiation Therapy
- Bevacizumab
- Paclitaxel
- Carboplatin
- Brachytherapy
- Pembrolizumab
Breakdown of trials Babak Edraki, MD has run
Cancer
Ovarian Cancer
Fallopian Tube Cancer
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Babak Edraki, MD specialize in?
Babak Edraki, MD focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage II.
Is Babak Edraki, MD currently recruiting for clinical trials?
Yes, Babak Edraki, MD is currently recruiting for 2 clinical trials in Concord California. If you're interested in participating, you should apply.
Are there any treatments that Babak Edraki, MD has studied deeply?
Yes, Babak Edraki, MD has studied treatments such as External Beam Radiation Therapy, Bevacizumab, Paclitaxel.
What is the best way to schedule an appointment with Babak Edraki, MD?
Apply for one of the trials that Babak Edraki, MD is conducting.
What is the office address of Babak Edraki, MD?
The office of Babak Edraki, MD is located at: John Muir Medical Center-Concord Campus, Concord, California 94520 United States. This is the address for their practice at the John Muir Medical Center-Concord Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.